Our expert, the pharmacist Maria Moya, has returned from a visit to Venezuela. She conducted 11 GSDP technical visits of 11 suppliers located in 5 different municipalities. The assessments were done on the behalf of (and funded by): MDM Spain, International Rescue Committee, Save the Children International, Première Urgence International, Action Contre la Faim Spain ...
Quamed would like to thank its members, partners, friends and followers for the ample support we received this year. This updated summary of our activities shows what that support has enabled us to do in 2022.
Ref. CIOMS Special Newsletter “Fighting antimicrobial resistance”, November 2022 Dear Friends, Antimicrobial Resistance (AMR), including bacterial resistance to antibiotics, is among the major concerns for global health. This short newsletter of the Council for International Organizations of Medical Sciences (CIOMS) provides an overview of the situation, and a list of key-references for further reading. The ...
The QUAMED director Ed Vreeke participates in the Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen ( 28 November-01 December 2022). The title of the meeting is Global Health Supplies: Paradigm Shifts in Market Authorization, Procurement and Supply Chains Approach. We are represented to learn more about the quality assurance systems of suppliers and the QA needs of procurers ...
Ref. Jenkins D, Diallo C, Payne M. Detecting falsified oral contraceptives by visual assessment and diffuse reflectance spectroscopy (350-2500 nm): the need for supplementing traditional pharmacopeia techniques and the public health implications. Heliyon. 2022 Oct 1;8(10):e10837. Dear Friends, Today I wish to share a contribution from David Jenkins and colleagues from FHI 360. For those ...
The Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation is inviting researchers in the field of pharmaceutical policy analysis and regulatory science on 11-12 January 2023 for a Winter meeting, with keynote lectures to be delivered around the central theme of evidence generation along the drug life cycle and a thesis defence from Tina ...
We are happy to inform you that QUAMED is now ISO9001:2015 certified, thanks to the hard work done by our operational team and the volunteers from our Technical Committee. The audit was conducted by BSI. Our efforts started in 2020 when we started working on expanding our internal policies, processes and procedures and making them ...
Be-Cause health has organised a call for abstracts and organised sessions: Breaking Taboos in Global Health. When: 23/03 24/03/2023 CET There are many challenges that still hinder access to equitable health, among which colonisation, discrimination and racism, unequal access to essential health services and quality medicines, and many more. Be-cause health, a platform of stakeholders ...
QUAMED is part of the World Health Organization’s Coalition of Interested Parties As formulated by the WHO: “The purpose of CIP is to establish and promote a unified, strategic and coordinated approach to national and regional RSS, with a view to enhancing access to safe, effective and quality medical products”. This aligns perfectly with our vision and ...
The WHO Medical Product Alert refers to 8 sub-standard products, identified in South-East Asia. These products were identified in Indonesia and reported by the natural regulatory authority (Badan POM) on 20 and 30 Oct 2022. The 8 products were: Termorex syrup, Flurin DMP syrup, Unibebi Cough Syrup, Unibebi Demam Paracetamol Drops, Unibebi Demam Paracetamol Syrup, ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.